Session: OS2
Session 2 Gut Microbiota & LSEC

Xian-yang Qin (RIKEN CLST), Mitsuko Hara (RIKEN CLST), Yutaka Furutani (RIKEN CLST), Kotaro Sakata (Wakunaga Pharmaceutical Co. Ltd.), Koichi Tamura (Wakunaga Pharmaceutical Co. Ltd.), Takami Oka (Wakunaga Pharmaceutical Co. Ltd.), Soichi Kojima (RIKEN CLST)

Daniel Patten (University of Birmingham), Sivesh Kamarajah (University of Birmingham), Emma Shepherd (University of Birmingham), Joseph Tickle (University of Birmingham), David Adams (University of Birmingham), Chris Weston (University of Birmingham), Shishir Shetty (University of Birmingham)

Le Thi Thanh Thuy (Osaka City University), Tuong Thi Van Thuy (Osaka City University), Hoang Hai (Osaka City University), Katsutoshi Yoshizato (Osaka City University; PhoenixBio Co. Ltd., Hiroshima, Japan), Norifumi Kawada (Osaka City University)

Wayne Yokoyama (Howard Hughes Medical Institute, Washington University School of Medicine), Dorothy Sojka (Washington University School of Medicine), Han Xian Aw Yeang (Washington University in St. Louis), Zhigang Tian (University of Science and Technology in China)

Ngatiman M. Hairulhisyam (National university of Ireland, Galway), Muhamad Marlini (National university of Ireland, Galway), Rahim Nur Syahrina (Universiti Sains Islam Malaysia), Pawel Kubica (Politechnika Gdańska), Beth Mallard (National university of Ireland, Galway), Peter Dockery (National university of Ireland, Galway), Antony Wheatley (National university of Ireland, Galway)